Trinity Biotech PLC

TRIB

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000888721

SEC filings (opens in a new tab)

No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Trinity Biotech PLC changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of TRIB: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	20	20	0
Shares	6.58M	6.32M	−253.4K (−3.9%)
Value	$6.51M	$5.96M	−$550.2K (−8.4%)

New holders (2)

Institutions that held Trinity Biotech PLC at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to TRIB in Q1 2023
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	22,271	$20.9K	0.00%
Susquehanna International Group, LLP	14,684	$13.8K	0.00%

Sold out (2)

Institutions that held Trinity Biotech PLC at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of TRIB in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
LPL Financial LLC	26,000	$25.7K
Virtu Financial LLC	12,381	$12.0K